INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 50 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,039,000 | -11.6% | 1,292,000 | -17.2% | 0.00% | 0.0% |
| Q2 2020 | $1,175,000 | +35.8% | 1,561,000 | +44.4% | 0.00% | 0.0% |
| Q1 2020 | $865,000 | -3.4% | 1,081,000 | +21.7% | 0.00% | 0.0% |
| Q4 2019 | $895,000 | -56.3% | 888,000 | -61.4% | 0.00% | 0.0% |
| Q2 2019 | $2,048,000 | +33.1% | 2,298,000 | +47.7% | 0.00% | 0.0% |
| Q1 2019 | $1,539,000 | -10.5% | 1,556,000 | -30.1% | 0.00% | 0.0% |
| Q3 2017 | $1,720,000 | +27.8% | 2,227,000 | +60.8% | 0.00% | 0.0% |
| Q2 2017 | $1,346,000 | +29.2% | 1,385,000 | +23.8% | 0.00% | 0.0% |
| Q1 2017 | $1,042,000 | +88.8% | 1,119,000 | +80.5% | 0.00% | – |
| Q4 2016 | $552,000 | -34.8% | 620,000 | -18.1% | 0.00% | -100.0% |
| Q3 2016 | $846,000 | – | 757,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|